Loricrin (LOR) Peptide
LOR
Reactivity: Human
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN979528
Quick Overview for Loricrin (LOR) Peptide (ABIN979528)
Target
LOR
(Loricrin (LOR))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-LOR antibody (Catalog #: ARP41738_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LOR (Loricrin (LOR))
-
Target Type
- Chemical
-
Background
-
LOR is a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in this gene are associated with Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.LOR encodes loricrin, a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in LOR may be the cause of both Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.
Alias Symbols: MGC111513
Protein Interaction Partner: EVPL,SPRR3,VIM,CSTA,IVL,KRT1,LOR,PI3,VIM
Protein Size: 316 -
Molecular Weight
- 35 kDa
-
Gene ID
- 4014
-
NCBI Accession
- NM_000427, NP_000418
-
UniProt
- P23490
Target
-
You are here:
